Search results
Earnings call: Veracyte sees robust growth driven by diagnostics platform By Investing.com
Investing.com· 2 days agoVeracyte, Inc. (NASDAQ:VCYT), a global genomic diagnostics company, has reported a strong financial...
GC Genome to Present New Clinical Data on Colorectal Cancer Detection at the ASCO Annual Meeting...
NBC 10 - FOX 14 Monroe· 3 days agoGC Genome Corporation, a leading diagnostics company, today announced that it will present the new clinical data of its AI-based liquid biopsy platform on colorectal cancer ...
Q1 2024 ACV Auctions Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 1 day agoOur Guard to that continues to leverage some of the industry's best artificial intelligence for vehicle condition, diagnostics for the addition of Monks exterior cosmetic ...
Hologic, Inc. (NASDAQ:HOLX) Q2 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 7 days agoHologic, Inc. (NASDAQ:HOLX) Q2 2024 Earnings Call Transcript May 2, 2024 Hologic, Inc. beats...
Natera CFO sells over $175k in company stock By Investing.com
Investing.com· 7 days agoNatera, Inc. (NASDAQ:NTRA) has reported a significant stock transaction involving its Chief...
Earnings call: Bio-Rad sees decline in Q1 sales but maintains full-year outlook By Investing.com
Investing.com· 2 days agoIn the first quarter of 2024, Bio-Rad Laboratories, Inc. (NYSE: NYSE:BIO) reported a decrease in net...
SERA PROGNOSTICS REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS
Char-Koosta News· 2 days agoSera Prognostics Inc., The Pregnancy Company® (Nasdaq: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy biomarker information to ...
Earl Blumenauer of Oregon's 3rd district adjusts retirement portfolio with multiple stock...
Investing.com· 4 days agoEarl Blumenauer of Oregon's 3rd district adjusts retirement portfolio with multiple stock...
Small Business - Cordele Dispatch | Cordele Dispatch
Cordele Dispatch· 6 days agoSecond Opinion Expert Announces OC FERTILITY® + OC BIOGENIX® To Join Its Panel To Provide Expert Second Opinions. PR Newswire DANA POINT, Calif., May 4, 2024 Patients will benefit from OC Fertility + OC Biogenix®'s expertise for complex fertility
Earnings call: Fulgent Genetics sees Q1 growth, targets higher margins By Investing.com
Investing.com· 7 days agoFulgent Genetics (NYSE: NASDAQ:FLGT), a provider of comprehensive genetic testing solutions, has...
